Description

Foracort 200: Budesonide 200mcg COPD Relief

A prescription combination inhaler, Foracort 200 contains budesonide (200 mcg) and formoterol (6 mcg), indicated for long-term management of asthma and COPD in adults. In the UK, the same active ingredients are available under the brand name Symbicort. Prior to beginning any treatment, consultation with a qualified UK healthcare professional is strongly advised. Patients prescribed budesonide and formoterol in the UK should be aware that different brand names may be encountered at registered pharmacies.

Foracort inhaler 200, which contains the same active ingredients as Symbicort, a widely prescribed UK reference brand.
Both budesonide and formoterol are individually well established in UK respiratory medicine.
Foracort 200 combines both at fixed doses in a single inhaler.
Whether this combination is clinically appropriate for you should always be assessed by a doctor prior to commencing treatment.

Composition

Active Components:

• Budesonide – 200 mcg
• Formoterol Fumarate Dihydrate – 6 mcg

Also Available As:

• Foracort 100
• Foracort 400
• Foracort Respules
• Foracort Junior
• Foracort G

Manufacturer

Cipla Limited.

Expiry Date

Expires on or after: Depending on the batch

About Foracort 200

Feature	Details
Primary Brand	Foracort 200
Active Ingredients	Budesonide 200 mcg + Formoterol Fumarate Dihydrate 6 mcg
Drug Class	Corticosteroid + Long-acting β2-agonist (LABA)
Prescription Status	Prescription-only medicine (POM)
Therapeutic Use	Asthma and COPD — long-term maintenance
Manufacturer	Cipla Limited
UK Reference Brand	Symbicort (budesonide + formoterol)

Foracort 200 vs Symbicort

Parameter	Foracort 200	Symbicort
Active Ingredients	Budesonide + Formoterol	Budesonide + Formoterol
Strength	200 mcg + 6 mcg	200 mcg + 6 mcg
Mechanism	Corticosteroid + LABA	Corticosteroid + LABA
Chemical Class	Corticosteroid + Long-acting β2-agonist	Corticosteroid + Long-acting β2-agonist
Bioequivalence	Same active salts	Reference standard
Therapeutic Effect	Asthma and COPD maintenance	Asthma and COPD maintenance

Both products contain identical active ingredients, budesonide and formoterol.

Your doctor is best placed to advise on which brand suits your individual clinical circumstances.

Understanding How Budesonide and Formoterol Act in the Body

An inhaled corticosteroid, budesonide works by reducing airway inflammation and irritation, thereby helping to prevent asthma attacks.

Acting directly within the lungs, it minimises systemic exposure when compared with oral steroids

As a long-acting beta2-agonist (LABA), formoterol works by relaxing the muscles that surround the airways, widening them to ease breathing.

This widens the airways, making breathing easier.

It acts within minutes and provides bronchodilation for up to 12 hours.

When used in combination, budesonide and formoterol target both the inflammatory and bronchospastic components associated with asthma and COPD.

This dual action helps control wheezing, chest tightness, persistent cough, and breathlessness.

When Doctors Prescribe Foracort 200

Two primary chronic respiratory conditions form the clinical basis for prescribing Cipla Foracort 200:

Characterised by airway inflammation and bronchospasm, asthma responds to the dual action delivered by Foracort 200. Regular use reduces the frequency of attacks and improves daily lung function.

Long-term exposure to airway irritants gives rise to COPD, which encompasses chronic bronchitis and emphysema.

Foracort 200 helps manage persistent airway obstruction and reduces exacerbations.

UK prescribing practice favours starting patients on the lowest effective dose.

A doctor will assess your condition, lung function, and symptom severity before prescribing.

Always follow your doctor’s clinical guidance throughout treatment.

Benefits of Foracort 200

Foracort 200 delivers both anti-inflammatory and bronchodilatory effects in one inhaler.

This simplifies treatment for patients who require both actions simultaneously.

Delivering the medicine directly to the lungs maximises local therapeutic effect and minimises systemic side effects relative to oral corticosteroids.

Patients typically report improved breathing, better exercise tolerance, and reduced reliance on short-acting reliever inhalers.

Formoterol’s rapid onset reassures during breathlessness peaks, but it does not replace a short-acting reliever.

How to Use Foracort 200 Inhaler

• Prior to handling the inhaler, ensure your hands are thoroughly washed
• Give the inhaler a thorough shake before every use
• Empty your lungs completely before positioning the mouthpiece between your teeth
• Whilst drawing in a slow, deep breath, apply firm downward pressure to the canister
• Hold your breath for up to ten seconds, then breathe out slowly
• To lower the risk of oral thrush developing, rinse your mouth well with water following every use
• Do not exceed your prescribed daily dose, and always speak to your doctor before discontinuing use of the inhaler

Possible Side Effects

Like any medicine, Foracort 200 can cause side effects.
These reflect the activity of both budesonide and formoterol.

Side Effect	Category
Coughing, hoarseness, throat inflammation	Common
Headache and nausea	Common
Oral thrush — white patches inside the mouth	Common
Low potassium levels	Less Common
Palpitations	Less Common
Changes in vision	Less Common
Difficulty breathing or chest pain	⚠️ Seek immediate medical attention
Severe allergic reaction — rash, swelling, or difficulty breathing	⚠️ Seek immediate medical attention

The risk of oral thrush is significantly reduced by rinsing your mouth following every use.
Your doctor should be informed promptly of any side effects that are either unexpected or fail to resolve.

Important Safety Advice

Tell your doctor if you have or have had any of the following:

• Liver disease
• Cardiovascular conditions
• Low potassium levels
• Diabetes
• Osteoporosis
• Tuberculosis, or known allergies to corticosteroids or bronchodilators

Liver

In the presence of liver disease, caution is advised and dose adjustments may be necessary under specialist guidance

Kidney

No dose adjustment is generally required. Use under medical supervision.

Alcohol

Alcohol does not interact directly with budesonide or formoterol. However, alcohol may worsen respiratory symptoms in asthma and COPD patients.
Limit consumption accordingly.

Driving

Foracort 200 may cause dizziness in rare cases.
If light-headedness occurs following use, driving or operating heavy machinery should be avoided.

Pregnancy

Treatment should only proceed under medical supervision and where the clinical benefit is considered to outweigh potential risk. Your doctor will assess this individually.

Breastfeeding

Breast milk may contain trace levels of budesonide. Whilst breastfeeding, this medicine should only be used where a doctor is directly supervising your care.

When to seek urgent medical attention:

• Breathing difficulties worsen despite regular use
• You experience hoarseness, persistent throat irritation, or oral thrush
• You experience allergic reactions, rash, facial swelling, or difficulty breathing
• Your asthma suddenly deteriorates, or you require reliever inhalers more frequently

Drug interactions

Inform your doctor and dispensing pharmacist or GP of all current medicines before starting Foracort 200.

Beta-blockers, certain antifungals, and other bronchodilators may interact with budesonide or formoterol.

Any side effects experienced should be submitted via the MHRA Yellow Card Scheme, accessible at yellowcard.mhra.gov.uk.

Always obtain advice from a qualified UK healthcare professional before initiating or modifying any treatment.

Missed Dose

• As soon as you recall a missed dose, take it promptly
• Where your next dose is due shortly, the missed dose should simply be omitted
• Do not take a double dose in an attempt to make up for one that has been missed
• Contact your doctor if you are unsure

Additional Information

Property	Details
Habit Forming	No
Chemical Class	Corticosteroid + Long-acting β2 agonist
Therapeutic Class	Respiratory agents
Action Class	Inhaled anti-inflammatory and bronchodilator

Storage and Responsible Access

Store the inhaler at a temperature below 25°C, in a location away from direct sunlight and heat sources, and always out of children‘s reach.

Do not use the inhaler if the device seal is broken or the canister appears damaged.

Being a prescription-only medicine, a valid prescription from a registered UK healthcare professional is required to obtain Foracort 200.

A GPhC-registered pharmacy should always be used

Counterfeit inhalers obtained from unregistered online sources are the subject of ongoing MHRA warnings.

FAQs

Q: What are the side effects of Foracort steroids?

A: Among the side effects reported with some regularity are throat irritation, hoarseness, and oral thrush. Rinsing the mouth after every use is strongly recommended. Any serious effects should be reported to your doctor promptly.

Q: Is it safe to take Foracort daily?

A: Foracort 200 is intended for daily long-term use. Regular treatment reviews will be conducted by your doctor to confirm the medicine continues to be appropriate for your needs.

Q: What are the long-term side effects of steroid inhalers?

A: Long-term use may affect bone density and adrenal function. Inhaled budesonide carries fewer systemic risks than oral steroids. Regular medical review is recommended.

Q: What is Foracort 200 used for?

A: Foracort 200 treats asthma and COPD in adults. It contains budesonide 200 mcg and formoterol 6 mcg. It is a prescription-only maintenance inhaler.

Conclusion

By combining budesonide and formoterol within a single maintenance inhaler, Foracort 200 delivers dual anti-inflammatory and bronchodilatory action. For patients with asthma or COPD requiring both mechanisms, it offers a clinically appropriate maintenance option under medical supervision.

In the UK, both active ingredients are also available as Symbicort, a licensed reference brand prescribed through established clinical pathways. The most suitable product for your individual clinical needs is best determined by your doctor. Guidance from a qualified UK healthcare professional should always be sought before any prescription treatment is initiated, adjusted, or altered

References

• NHS. Asthma. www.nhs.uk
• MHRA. Budesonide Regulatory Guidance. www.gov.uk/mhra
• NICE. Asthma — diagnosis, monitoring and chronic asthma management. www.nice.org.uk
• EMA. Symbicort — Summary of Product Characteristics. www.ema.europa.eu

Medical Disclaimer

This article is for informational purposes only and does not replace professional medical advice. Always consult a qualified UK healthcare professional before starting, adjusting, or stopping any medicine.